0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fluorinated Pharmaceutical Intermediates Market Research Report 2023
Published Date: February 2023
|
Report Code: QYRE-Auto-18A12300
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Fluorinated Pharmaceutical Intermediates Market Research Report 2022
BUY CHAPTERS

Global Fluorinated Pharmaceutical Intermediates Market Research Report 2023

Code: QYRE-Auto-18A12300
Report
February 2023
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Fluorinated Pharmaceutical Intermediates Market

Fluorine-containing intermediates are chemical raw materials or chemical products used in the process of drug synthesis. Such chemical products can be produced in ordinary chemical plants without a drug production license. Can be used for the synthesis of drugs.
The global Fluorinated Pharmaceutical Intermediates market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Fluorinated Pharmaceutical Intermediates is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Fluorinated Pharmaceutical Intermediates is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Fluorinated Pharmaceutical Intermediates in Antiviral Drug is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Fluorinated Pharmaceutical Intermediates include Lonza, Catalent, Patheon, BASF, Jubilant, Granules, Ganesh, Chemcon and Chemours, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Fluorinated Pharmaceutical Intermediates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fluorinated Pharmaceutical Intermediates.
The Fluorinated Pharmaceutical Intermediates market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Fluorinated Pharmaceutical Intermediates market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fluorinated Pharmaceutical Intermediates companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Key Segmentations

By Company

  • Lonza
  • Catalent
  • Patheon
  • BASF
  • Jubilant
  • Granules
  • Ganesh
  • Chemcon
  • Chemours
  • Zhejiang Yongtai Technology
  • Shenzhen Capchem Technology
  • Zhejiang Zhongxin Fluoride Materials
  • Jiangsu Feiyu Technology
  • Shanghai Sinofluoro
  • Shanghai Aqbiopharma
  • Hangzhou Fluoro Pharmaceutical
  • Zhejiang Dayang Biotech
  • Shandong Feiyuan Group

Segment by Type

  • Aromatic Fluoride
  • Aliphatic Fluoride

Segment by Application

  • Antiviral Drug
  • Anti-infectives Drug
  • Antirheumatic Drug
  • Antibacterial Drug
  • Others

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Fluorinated Pharmaceutical Intermediates companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

Scope of Global Fluorinated Pharmaceutical Intermediates Market Report

Report MetricDetails
Report NameGlobal Fluorinated Pharmaceutical Intermediates Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Aromatic Fluoride
1.2.3 Aliphatic Fluoride
1.3 Market by Application
1.3.1 Global Fluorinated Pharmaceutical Intermediates Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Antiviral Drug
1.3.3 Anti-infectives Drug
1.3.4 Antirheumatic Drug
1.3.5 Antibacterial Drug
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fluorinated Pharmaceutical Intermediates Market Perspective (2018-2029)
2.2 Fluorinated Pharmaceutical Intermediates Growth Trends by Region
2.2.1 Global Fluorinated Pharmaceutical Intermediates Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Fluorinated Pharmaceutical Intermediates Historic Market Size by Region (2018-2023)
2.2.3 Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Region (2024-2029)
2.3 Fluorinated Pharmaceutical Intermediates Market Dynamics
2.3.1 Fluorinated Pharmaceutical Intermediates Industry Trends
2.3.2 Fluorinated Pharmaceutical Intermediates Market Drivers
2.3.3 Fluorinated Pharmaceutical Intermediates Market Challenges
2.3.4 Fluorinated Pharmaceutical Intermediates Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fluorinated Pharmaceutical Intermediates Players by Revenue
3.1.1 Global Top Fluorinated Pharmaceutical Intermediates Players by Revenue (2018-2023)
3.1.2 Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Players (2018-2023)
3.2 Global Fluorinated Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fluorinated Pharmaceutical Intermediates Revenue
3.4 Global Fluorinated Pharmaceutical Intermediates Market Concentration Ratio
3.4.1 Global Fluorinated Pharmaceutical Intermediates Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fluorinated Pharmaceutical Intermediates Revenue in 2022
3.5 Fluorinated Pharmaceutical Intermediates Key Players Head office and Area Served
3.6 Key Players Fluorinated Pharmaceutical Intermediates Product Solution and Service
3.7 Date of Enter into Fluorinated Pharmaceutical Intermediates Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fluorinated Pharmaceutical Intermediates Breakdown Data by Type
4.1 Global Fluorinated Pharmaceutical Intermediates Historic Market Size by Type (2018-2023)
4.2 Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Type (2024-2029)
5 Fluorinated Pharmaceutical Intermediates Breakdown Data by Application
5.1 Global Fluorinated Pharmaceutical Intermediates Historic Market Size by Application (2018-2023)
5.2 Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Fluorinated Pharmaceutical Intermediates Market Size (2018-2029)
6.2 North America Fluorinated Pharmaceutical Intermediates Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2018-2023)
6.4 North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fluorinated Pharmaceutical Intermediates Market Size (2018-2029)
7.2 Europe Fluorinated Pharmaceutical Intermediates Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2018-2023)
7.4 Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size (2018-2029)
8.2 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2018-2023)
8.4 Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fluorinated Pharmaceutical Intermediates Market Size (2018-2029)
9.2 Latin America Fluorinated Pharmaceutical Intermediates Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2018-2023)
9.4 Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size (2018-2029)
10.2 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2018-2023)
10.4 Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Fluorinated Pharmaceutical Intermediates Introduction
11.1.4 Lonza Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Detail
11.2.2 Catalent Business Overview
11.2.3 Catalent Fluorinated Pharmaceutical Intermediates Introduction
11.2.4 Catalent Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.2.5 Catalent Recent Development
11.3 Patheon
11.3.1 Patheon Company Detail
11.3.2 Patheon Business Overview
11.3.3 Patheon Fluorinated Pharmaceutical Intermediates Introduction
11.3.4 Patheon Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.3.5 Patheon Recent Development
11.4 BASF
11.4.1 BASF Company Detail
11.4.2 BASF Business Overview
11.4.3 BASF Fluorinated Pharmaceutical Intermediates Introduction
11.4.4 BASF Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.4.5 BASF Recent Development
11.5 Jubilant
11.5.1 Jubilant Company Detail
11.5.2 Jubilant Business Overview
11.5.3 Jubilant Fluorinated Pharmaceutical Intermediates Introduction
11.5.4 Jubilant Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.5.5 Jubilant Recent Development
11.6 Granules
11.6.1 Granules Company Detail
11.6.2 Granules Business Overview
11.6.3 Granules Fluorinated Pharmaceutical Intermediates Introduction
11.6.4 Granules Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.6.5 Granules Recent Development
11.7 Ganesh
11.7.1 Ganesh Company Detail
11.7.2 Ganesh Business Overview
11.7.3 Ganesh Fluorinated Pharmaceutical Intermediates Introduction
11.7.4 Ganesh Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.7.5 Ganesh Recent Development
11.8 Chemcon
11.8.1 Chemcon Company Detail
11.8.2 Chemcon Business Overview
11.8.3 Chemcon Fluorinated Pharmaceutical Intermediates Introduction
11.8.4 Chemcon Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.8.5 Chemcon Recent Development
11.9 Chemours
11.9.1 Chemours Company Detail
11.9.2 Chemours Business Overview
11.9.3 Chemours Fluorinated Pharmaceutical Intermediates Introduction
11.9.4 Chemours Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.9.5 Chemours Recent Development
11.10 Zhejiang Yongtai Technology
11.10.1 Zhejiang Yongtai Technology Company Detail
11.10.2 Zhejiang Yongtai Technology Business Overview
11.10.3 Zhejiang Yongtai Technology Fluorinated Pharmaceutical Intermediates Introduction
11.10.4 Zhejiang Yongtai Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.10.5 Zhejiang Yongtai Technology Recent Development
11.11 Shenzhen Capchem Technology
11.11.1 Shenzhen Capchem Technology Company Detail
11.11.2 Shenzhen Capchem Technology Business Overview
11.11.3 Shenzhen Capchem Technology Fluorinated Pharmaceutical Intermediates Introduction
11.11.4 Shenzhen Capchem Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.11.5 Shenzhen Capchem Technology Recent Development
11.12 Zhejiang Zhongxin Fluoride Materials
11.12.1 Zhejiang Zhongxin Fluoride Materials Company Detail
11.12.2 Zhejiang Zhongxin Fluoride Materials Business Overview
11.12.3 Zhejiang Zhongxin Fluoride Materials Fluorinated Pharmaceutical Intermediates Introduction
11.12.4 Zhejiang Zhongxin Fluoride Materials Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.12.5 Zhejiang Zhongxin Fluoride Materials Recent Development
11.13 Jiangsu Feiyu Technology
11.13.1 Jiangsu Feiyu Technology Company Detail
11.13.2 Jiangsu Feiyu Technology Business Overview
11.13.3 Jiangsu Feiyu Technology Fluorinated Pharmaceutical Intermediates Introduction
11.13.4 Jiangsu Feiyu Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.13.5 Jiangsu Feiyu Technology Recent Development
11.14 Shanghai Sinofluoro
11.14.1 Shanghai Sinofluoro Company Detail
11.14.2 Shanghai Sinofluoro Business Overview
11.14.3 Shanghai Sinofluoro Fluorinated Pharmaceutical Intermediates Introduction
11.14.4 Shanghai Sinofluoro Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.14.5 Shanghai Sinofluoro Recent Development
11.15 Shanghai Aqbiopharma
11.15.1 Shanghai Aqbiopharma Company Detail
11.15.2 Shanghai Aqbiopharma Business Overview
11.15.3 Shanghai Aqbiopharma Fluorinated Pharmaceutical Intermediates Introduction
11.15.4 Shanghai Aqbiopharma Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.15.5 Shanghai Aqbiopharma Recent Development
11.16 Hangzhou Fluoro Pharmaceutical
11.16.1 Hangzhou Fluoro Pharmaceutical Company Detail
11.16.2 Hangzhou Fluoro Pharmaceutical Business Overview
11.16.3 Hangzhou Fluoro Pharmaceutical Fluorinated Pharmaceutical Intermediates Introduction
11.16.4 Hangzhou Fluoro Pharmaceutical Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.16.5 Hangzhou Fluoro Pharmaceutical Recent Development
11.17 Zhejiang Dayang Biotech
11.17.1 Zhejiang Dayang Biotech Company Detail
11.17.2 Zhejiang Dayang Biotech Business Overview
11.17.3 Zhejiang Dayang Biotech Fluorinated Pharmaceutical Intermediates Introduction
11.17.4 Zhejiang Dayang Biotech Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.17.5 Zhejiang Dayang Biotech Recent Development
11.18 Shandong Feiyuan Group
11.18.1 Shandong Feiyuan Group Company Detail
11.18.2 Shandong Feiyuan Group Business Overview
11.18.3 Shandong Feiyuan Group Fluorinated Pharmaceutical Intermediates Introduction
11.18.4 Shandong Feiyuan Group Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
11.18.5 Shandong Feiyuan Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Aromatic Fluoride
    Table 3. Key Players of Aliphatic Fluoride
    Table 4. Global Fluorinated Pharmaceutical Intermediates Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global Fluorinated Pharmaceutical Intermediates Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Fluorinated Pharmaceutical Intermediates Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Fluorinated Pharmaceutical Intermediates Market Share by Region (2018-2023)
    Table 8. Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Fluorinated Pharmaceutical Intermediates Market Share by Region (2024-2029)
    Table 10. Fluorinated Pharmaceutical Intermediates Market Trends
    Table 11. Fluorinated Pharmaceutical Intermediates Market Drivers
    Table 12. Fluorinated Pharmaceutical Intermediates Market Challenges
    Table 13. Fluorinated Pharmaceutical Intermediates Market Restraints
    Table 14. Global Fluorinated Pharmaceutical Intermediates Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Fluorinated Pharmaceutical Intermediates Market Share by Players (2018-2023)
    Table 16. Global Top Fluorinated Pharmaceutical Intermediates Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fluorinated Pharmaceutical Intermediates as of 2022)
    Table 17. Ranking of Global Top Fluorinated Pharmaceutical Intermediates Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by Fluorinated Pharmaceutical Intermediates Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Fluorinated Pharmaceutical Intermediates Product Solution and Service
    Table 21. Date of Enter into Fluorinated Pharmaceutical Intermediates Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Fluorinated Pharmaceutical Intermediates Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Type (2018-2023)
    Table 25. Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Type (2024-2029)
    Table 27. Global Fluorinated Pharmaceutical Intermediates Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Application (2018-2023)
    Table 29. Global Fluorinated Pharmaceutical Intermediates Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Fluorinated Pharmaceutical Intermediates Revenue Market Share by Application (2024-2029)
    Table 31. North America Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America Fluorinated Pharmaceutical Intermediates Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe Fluorinated Pharmaceutical Intermediates Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America Fluorinated Pharmaceutical Intermediates Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Lonza Company Detail
    Table 47. Lonza Business Overview
    Table 48. Lonza Fluorinated Pharmaceutical Intermediates Product
    Table 49. Lonza Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 50. Lonza Recent Development
    Table 51. Catalent Company Detail
    Table 52. Catalent Business Overview
    Table 53. Catalent Fluorinated Pharmaceutical Intermediates Product
    Table 54. Catalent Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 55. Catalent Recent Development
    Table 56. Patheon Company Detail
    Table 57. Patheon Business Overview
    Table 58. Patheon Fluorinated Pharmaceutical Intermediates Product
    Table 59. Patheon Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 60. Patheon Recent Development
    Table 61. BASF Company Detail
    Table 62. BASF Business Overview
    Table 63. BASF Fluorinated Pharmaceutical Intermediates Product
    Table 64. BASF Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 65. BASF Recent Development
    Table 66. Jubilant Company Detail
    Table 67. Jubilant Business Overview
    Table 68. Jubilant Fluorinated Pharmaceutical Intermediates Product
    Table 69. Jubilant Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 70. Jubilant Recent Development
    Table 71. Granules Company Detail
    Table 72. Granules Business Overview
    Table 73. Granules Fluorinated Pharmaceutical Intermediates Product
    Table 74. Granules Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 75. Granules Recent Development
    Table 76. Ganesh Company Detail
    Table 77. Ganesh Business Overview
    Table 78. Ganesh Fluorinated Pharmaceutical Intermediates Product
    Table 79. Ganesh Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 80. Ganesh Recent Development
    Table 81. Chemcon Company Detail
    Table 82. Chemcon Business Overview
    Table 83. Chemcon Fluorinated Pharmaceutical Intermediates Product
    Table 84. Chemcon Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 85. Chemcon Recent Development
    Table 86. Chemours Company Detail
    Table 87. Chemours Business Overview
    Table 88. Chemours Fluorinated Pharmaceutical Intermediates Product
    Table 89. Chemours Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 90. Chemours Recent Development
    Table 91. Zhejiang Yongtai Technology Company Detail
    Table 92. Zhejiang Yongtai Technology Business Overview
    Table 93. Zhejiang Yongtai Technology Fluorinated Pharmaceutical Intermediates Product
    Table 94. Zhejiang Yongtai Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 95. Zhejiang Yongtai Technology Recent Development
    Table 96. Shenzhen Capchem Technology Company Detail
    Table 97. Shenzhen Capchem Technology Business Overview
    Table 98. Shenzhen Capchem Technology Fluorinated Pharmaceutical Intermediates Product
    Table 99. Shenzhen Capchem Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 100. Shenzhen Capchem Technology Recent Development
    Table 101. Zhejiang Zhongxin Fluoride Materials Company Detail
    Table 102. Zhejiang Zhongxin Fluoride Materials Business Overview
    Table 103. Zhejiang Zhongxin Fluoride Materials Fluorinated Pharmaceutical Intermediates Product
    Table 104. Zhejiang Zhongxin Fluoride Materials Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 105. Zhejiang Zhongxin Fluoride Materials Recent Development
    Table 106. Jiangsu Feiyu Technology Company Detail
    Table 107. Jiangsu Feiyu Technology Business Overview
    Table 108. Jiangsu Feiyu Technology Fluorinated Pharmaceutical Intermediates Product
    Table 109. Jiangsu Feiyu Technology Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 110. Jiangsu Feiyu Technology Recent Development
    Table 111. Shanghai Sinofluoro Company Detail
    Table 112. Shanghai Sinofluoro Business Overview
    Table 113. Shanghai Sinofluoro Fluorinated Pharmaceutical Intermediates Product
    Table 114. Shanghai Sinofluoro Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 115. Shanghai Sinofluoro Recent Development
    Table 116. Shanghai Aqbiopharma Company Detail
    Table 117. Shanghai Aqbiopharma Business Overview
    Table 118. Shanghai Aqbiopharma Fluorinated Pharmaceutical Intermediates Product
    Table 119. Shanghai Aqbiopharma Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 120. Shanghai Aqbiopharma Recent Development
    Table 121. Hangzhou Fluoro Pharmaceutical Company Detail
    Table 122. Hangzhou Fluoro Pharmaceutical Business Overview
    Table 123. Hangzhou Fluoro Pharmaceutical Fluorinated Pharmaceutical Intermediates Product
    Table 124. Hangzhou Fluoro Pharmaceutical Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 125. Hangzhou Fluoro Pharmaceutical Recent Development
    Table 126. Zhejiang Dayang Biotech Company Detail
    Table 127. Zhejiang Dayang Biotech Business Overview
    Table 128. Zhejiang Dayang Biotech Fluorinated Pharmaceutical Intermediates Product
    Table 129. Zhejiang Dayang Biotech Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 130. Zhejiang Dayang Biotech Recent Development
    Table 131. Shandong Feiyuan Group Company Detail
    Table 132. Shandong Feiyuan Group Business Overview
    Table 133. Shandong Feiyuan Group Fluorinated Pharmaceutical Intermediates Product
    Table 134. Shandong Feiyuan Group Revenue in Fluorinated Pharmaceutical Intermediates Business (2018-2023) & (US$ Million)
    Table 135. Shandong Feiyuan Group Recent Development
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Fluorinated Pharmaceutical Intermediates Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Fluorinated Pharmaceutical Intermediates Market Share by Type: 2022 VS 2029
    Figure 3. Aromatic Fluoride Features
    Figure 4. Aliphatic Fluoride Features
    Figure 5. Global Fluorinated Pharmaceutical Intermediates Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 6. Global Fluorinated Pharmaceutical Intermediates Market Share by Application: 2022 VS 2029
    Figure 7. Antiviral Drug Case Studies
    Figure 8. Anti-infectives Drug Case Studies
    Figure 9. Antirheumatic Drug Case Studies
    Figure 10. Antibacterial Drug Case Studies
    Figure 11. Others Case Studies
    Figure 12. Fluorinated Pharmaceutical Intermediates Report Years Considered
    Figure 13. Global Fluorinated Pharmaceutical Intermediates Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 14. Global Fluorinated Pharmaceutical Intermediates Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Fluorinated Pharmaceutical Intermediates Market Share by Region: 2022 VS 2029
    Figure 16. Global Fluorinated Pharmaceutical Intermediates Market Share by Players in 2022
    Figure 17. Global Top Fluorinated Pharmaceutical Intermediates Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fluorinated Pharmaceutical Intermediates as of 2022)
    Figure 18. The Top 10 and 5 Players Market Share by Fluorinated Pharmaceutical Intermediates Revenue in 2022
    Figure 19. North America Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. North America Fluorinated Pharmaceutical Intermediates Market Share by Country (2018-2029)
    Figure 21. United States Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Canada Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Fluorinated Pharmaceutical Intermediates Market Share by Country (2018-2029)
    Figure 25. Germany Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. France Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. U.K. Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Italy Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Russia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Nordic Countries Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific Fluorinated Pharmaceutical Intermediates Market Share by Region (2018-2029)
    Figure 33. China Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Japan Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. South Korea Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Southeast Asia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. India Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Australia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America Fluorinated Pharmaceutical Intermediates Market Share by Country (2018-2029)
    Figure 41. Mexico Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Brazil Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa Fluorinated Pharmaceutical Intermediates Market Share by Country (2018-2029)
    Figure 45. Turkey Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Saudi Arabia Fluorinated Pharmaceutical Intermediates Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Lonza Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 48. Catalent Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 49. Patheon Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 50. BASF Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 51. Jubilant Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 52. Granules Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 53. Ganesh Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 54. Chemcon Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 55. Chemours Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 56. Zhejiang Yongtai Technology Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 57. Shenzhen Capchem Technology Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 58. Zhejiang Zhongxin Fluoride Materials Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 59. Jiangsu Feiyu Technology Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 60. Shanghai Sinofluoro Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 61. Shanghai Aqbiopharma Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 62. Hangzhou Fluoro Pharmaceutical Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 63. Zhejiang Dayang Biotech Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 64. Shandong Feiyuan Group Revenue Growth Rate in Fluorinated Pharmaceutical Intermediates Business (2018-2023)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS